Market Research Logo

Circassia Pharmaceuticals Plc - Product Pipeline Review - 2016

Circassia Pharmaceuticals Plc - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Circassia Pharmaceuticals Plc - Product Pipeline Review - 2016’, provides an overview of the Circassia Pharmaceuticals Plc’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Circassia Pharmaceuticals Plc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Circassia Pharmaceuticals Plc
  • The report provides overview of Circassia Pharmaceuticals Plc including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Circassia Pharmaceuticals Plc’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Circassia Pharmaceuticals Plc’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Circassia Pharmaceuticals Plc’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Circassia Pharmaceuticals Plc
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Circassia Pharmaceuticals Plc’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Circassia Pharmaceuticals Plc Snapshot
Circassia Pharmaceuticals Plc Overview
Key Information
Key Facts
Circassia Pharmaceuticals Plc - Research and Development Overview
Key Therapeutic Areas
Circassia Pharmaceuticals Plc - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Circassia Pharmaceuticals Plc - Pipeline Products Glance
Circassia Pharmaceuticals Plc - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Circassia Pharmaceuticals Plc - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Circassia Pharmaceuticals Plc - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Circassia Pharmaceuticals Plc - Drug Profiles
Vaccine for Grass-Induced Rhinoconjunctivitis and Asthma
Product Description
Mechanism of Action
R&D Progress
glycopyrronium bromide
Product Description
Mechanism of Action
R&D Progress
Vaccine for Asthma and Ragweed-Induced Rhinoconjunctivitis
Product Description
Mechanism of Action
R&D Progress
Vaccine for Birch Pollen Allergy
Product Description
Mechanism of Action
R&D Progress
Vaccine for House Dust Mite Induced Allergic Rhinoconjunctivitis
Product Description
Mechanism of Action
R&D Progress
(fluticasone propionate + glycopyrronium bromide + salmeterol xinafoate)
Product Description
Mechanism of Action
R&D Progress
Vaccine for Japanese Cedar Pollen Allergy
Product Description
Mechanism of Action
R&D Progress
(Inhaled Corticosteroid + Long-acting Muscarinic Antagonist)
Product Description
Mechanism of Action
R&D Progress
(Long Acting Beta-2 Agonist + Long Acting Muscarinic Receptor Antagonist)
Product Description
Mechanism of Action
R&D Progress
Vaccine for Alternaria Allergy
Product Description
Mechanism of Action
R&D Progress
Circassia Pharmaceuticals Plc - Pipeline Analysis
Circassia Pharmaceuticals Plc - Pipeline Products by Target
Circassia Pharmaceuticals Plc - Pipeline Products by Route of Administration
Circassia Pharmaceuticals Plc - Pipeline Products by Molecule Type
Circassia Pharmaceuticals Plc - Pipeline Products by Mechanism of Action
Circassia Pharmaceuticals Plc - Recent Pipeline Updates
Circassia Pharmaceuticals Plc - Dormant Projects
Circassia Pharmaceuticals Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Circassia Pharmaceuticals Plc, Key Information
Circassia Pharmaceuticals Plc, Key Facts
Circassia Pharmaceuticals Plc - Pipeline by Indication, 2016
Circassia Pharmaceuticals Plc - Pipeline by Stage of Development, 2016
Circassia Pharmaceuticals Plc - Monotherapy Products in Pipeline, 2016
Circassia Pharmaceuticals Plc - Combination Treatment Modalities in Pipeline, 2016
Circassia Pharmaceuticals Plc - Phase III, 2016
Circassia Pharmaceuticals Plc - Phase II, 2016
Circassia Pharmaceuticals Plc - Phase I, 2016
Circassia Pharmaceuticals Plc - Preclinical, 2016
Circassia Pharmaceuticals Plc - Pipeline by Target, 2016
Circassia Pharmaceuticals Plc - Pipeline by Route of Administration, 2016
Circassia Pharmaceuticals Plc - Pipeline by Molecule Type, 2016
Circassia Pharmaceuticals Plc - Pipeline Products by Mechanism of Action, 2016
Circassia Pharmaceuticals Plc - Recent Pipeline Updates, 2016
Circassia Pharmaceuticals Plc - Dormant Developmental Projects,2016
Circassia Pharmaceuticals Plc, Subsidiaries
List of Figures
Circassia Pharmaceuticals Plc - Pipeline by Top 10 Indication, 2016
Circassia Pharmaceuticals Plc - Pipeline by Stage of Development, 2016
Circassia Pharmaceuticals Plc - Monotherapy Products in Pipeline, 2016
Circassia Pharmaceuticals Plc - Combination Treatment Modalities in Pipeline, 2016
Circassia Pharmaceuticals Plc - Pipeline by Target, 2016
Circassia Pharmaceuticals Plc - Pipeline by Route of Administration, 2016
Circassia Pharmaceuticals Plc - Pipeline by Molecule Type, 2016
Circassia Pharmaceuticals Plc - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report